id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-D-1145-0041,FDA,FDA-2012-D-1145,Enrichment Strategies for Clinical Trials to Support Determination of Effectiveness of Human Drugs and Biological Products; Guidance for Industry,Other,Guidance,2019-03-15T04:00:00Z,2019,3,2019-03-15T04:00:00Z,,2024-11-12T22:57:27Z,,1,0,0900006483ae8344
FDA-2012-D-1145-0040,FDA,FDA-2012-D-1145,"Enrichment Strategies for Clinical Trials To Support Demonstration of
Effectiveness of Human Drugs and Biological Products; Guidance for
Industry; Availability",Notice,Notice of Availability,2019-03-15T04:00:00Z,2019,3,2019-03-15T04:00:00Z,,2019-03-15T13:51:58Z,2019-04815,0,0,0900006483ae7baf